novo nordisk weight loss - Search News

News

Novo Nordisk to sell weight-loss drug for $499

Fox Business on MSN · 2h

Novo Nordisk to sell weight-loss drug for $499 to eligible customers

Cash-paying type 2 diabetes patients in the United States can now access Novo Nordisk's Ozempic for $499 per month through multiple pharmacy platforms.

Weight-loss drug Wegovy launches in South Africa

The launch marked Danish drugmaker Novo Nordisk's debut on the continent, ramping up competition with rival Eli Lilly.

Financial Times · 3d

Weight-loss weariness and Trump threats wipe $250bn off Novo Nordisk and Eli Lilly

Trump’s push for price cuts and tariffs weighs on ‘obesity franchises’, which have missed out on equity market’s rise

Wegovy News Pushes Novo Nordisk Stock

Barron's on MSN · 2h

Wegovy News Pushes Novo Nordisk Stock Higher

Novo Nordisk’s wildly popular GLP-1 drug Wegovy has been approved for use against a serious form of liver disease.

Reuters on MSN · 10h

Shares in Novo Nordisk rise after Wegovy gets US nod for liver disease treatment

Shares in Novo Nordisk rose on Monday, after it got U.S. approval for its weight-loss drug Wegovy to treat a serious liver condition, positive news for the drugmaker that lost more than one-third of its market value in recent weeks.

MarketWatch on MSN · 10h

Novo Nordisk shares are rising. The FDA approves another use for Wegovy.

Novo Nordisk shares were climbing Monday after the Food and Drug Administration approved the popular weight-loss drug Wegovy to treat a form of liver disease. The FDA approved Wegovy for use in what’s called noncirrhotic metabolic dysfunction-associated steatohepatitis, or MASH, in adults with moderate to advanced liver fibrosis.

9h

Stocks to Watch Monday: Novo Nordisk, Soho House, UnitedHealth, Palo Alto

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease.

2hon MSN

Top Stock Movers Now: Dayforce, Novo Nordisk, First Solar, and More

Major U.S. equities indexes were little changed Monday morning, ahead of retail sector earnings reports and comments from ...

1hon MSN

Novo Nordisk slashes price of Ozempic in half to $499 for cash-paying, eligible U.S. patients

Novo Nordisk has announced a sweeping reduction in the cost of its blockbuster diabetes drug Ozempic, cutting the monthly ...

5h

Stocks to Watch Monday: Novo Nordisk, TeraWulf, UnitedHealth, Soho House

The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a [form of liver disease]( ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results